Cameroon Mobile Phone SMS Trial

NCT ID: NCT01247181

Last Updated: 2011-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adherence HIV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobile phone text message

Group Type EXPERIMENTAL

Mobile phone text message

Intervention Type OTHER

Weekly message with motivational content

No Mobile phone text message

Usual care provided at clinic

Group Type ACTIVE_COMPARATOR

Usual care

Intervention Type OTHER

Usual care provided at clinic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile phone text message

Weekly message with motivational content

Intervention Type OTHER

Usual care

Usual care provided at clinic

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SMS Texto Text message Routine care

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* On HAART for at least 1 month
* 21 years or more
* Owns a mobile phone
* Can read text messages

Exclusion Criteria

* On HAART for less than 1 month
* Aged less than 21 years
Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CIHR Canadian HIV Trials Network

NETWORK

Sponsor Role collaborator

Yaounde Central Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lawrence Mbuagbaw

MD, MPH

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lawrence Mbuagbaw, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Centre for the Development of Best Practices in Health

Pierre Ongolo-Zogo, MD, BSc

Role: STUDY_DIRECTOR

Centre for the Development of Best Practices in Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yaounde Central Hospital Accredited Treatment Centre

Yaoundé, Centre Region, Cameroon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Cameroon

References

Explore related publications, articles, or registry entries linked to this study.

Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12):e46909. doi: 10.1371/journal.pone.0046909. Epub 2012 Dec 6.

Reference Type DERIVED
PMID: 23236345 (View on PubMed)

Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink J, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA. The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials. 2011 Jan 7;12:5. doi: 10.1186/1745-6215-12-5.

Reference Type DERIVED
PMID: 21211064 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PACTR201011000261458

Identifier Type: REGISTRY

Identifier Source: secondary_id

CAMPS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Motivation Matters Study
NCT02627365 COMPLETED NA